Nura Bio

Clinical-stage biopharmaceutical company developing neuroprotective small molecule therapies.

Biotechnology 📍 South San Francisco, CA

Current Valuation

Private

PRIVATE

Clinical-stage biopharmaceutical company developing neuroprotective small molecule therapies. Headquartered in South San Francisco, CA. Raised $73.8M in Series B funding in June 2026 led by The Column Group.

Company Profile

CEO

Shilpa Sambashivan

South San Francisco, CA

Total Raised

$73.8M

Last Round

Series B — $73.8M (Jun 2026) · Lead: The Column Group

IPO Status

private

Fundraising Status

Series B · $73.8M · 2 mo ago

privateTotal raised $73.8M1 disclosed rounds

Funding History

Round	Amount	Date	Lead Investor	Post-Money
Series B	$73.8M	Jun 2026	The Column Group	—

Investors

The Column Group · Euclidean Capital · Samsara BioCapital · Sanofi Ventures

BiotechnologyBiopharmaceuticalsRecently Funded

Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.